U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H28N2O5
Molecular Weight 364.436
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CF-1368

SMILES

CCCCCCCCC1=CC2=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C(=O)N=C2O1

InChI

InChIKey=WNJULOODRKXPLP-GVDBMIGSSA-N
InChI=1S/C19H28N2O5/c1-2-3-4-5-6-7-8-14-9-13-11-21(19(24)20-18(13)25-14)17-10-15(23)16(12-22)26-17/h9,11,15-17,22-23H,2-8,10,12H2,1H3/t15-,16+,17+/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H28N2O5
Molecular Weight 364.436
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.
2004-03-19
Synthesis and antiviral evaluation of some 3'-fluoro bicyclic nucleoside analogues.
2004
Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues.
2003-05
Bicyclic nucleoside inhibitors of varicella-zoster virus: effect of terminal aryl substitution in the side-chain.
2002-09
Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
2002-07-18
Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
2002-05
Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
2002-02
Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents.
2001-09-21
Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of terminal unsaturation in the side chain.
2001-02-12
Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain.
2000-12-28
Anti-varicella-zoster virus bicyclic nucleosides: replacement of furo by pyrro base reduces antiviral potency.
2000-09
Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base.
1999-11-04
Substance Class Chemical
Created
by admin
on Wed Apr 02 11:28:44 GMT 2025
Edited
by admin
on Wed Apr 02 11:28:44 GMT 2025
Record UNII
K647SW1D14
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FURO(2,3-D)PYRIMIDIN-2(3H)-ONE, 3-(2-DEOXY-.BETA.-D-ERYTHRO-PENTOFURANOSYL)-6-OCTYL-
Preferred Name English
CF-1368
Common Name English
Code System Code Type Description
FDA UNII
K647SW1D14
Created by admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
PRIMARY
PUBCHEM
492114
Created by admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
PRIMARY
CAS
215668-64-7
Created by admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY